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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of a health claim related to 
Rosbacher drive
®
 and increased attention pursuant to 
Article 13(5) of Regulation (EC) No 1924/2006
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following an application from Hassia Mineralquellen GmbH & Co KG, submitted for authorisation of a health 
claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the 
scientific substantiation of a health claim related to Rosbacher drive
®
 and increased attention. The Panel 
considers that Rosbacher drive
®
, which contains natural mineral water plus grape juice, lemon juice, 
pomegranate juice, elderberry juice, isomaltulose, sucrose, fructose syrup, caffeine, ascorbic acid and natural 
flavourings, is sufficiently characterised. The claimed effect, increased attention, is a beneficial physiological 
effect. The single study which was carried out with Rosbacher drive
®
 was an open-label, non-randomised 
sequential study and the study did not report on any outcomes of attention. No conclusions can be drawn from 
this study for the scientific substantiation of the claim. The Panel concludes that a cause and effect relationship 
has not been established between the consumption of Rosbacher drive
®
 and increased attention. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following an application from Hassia Mineralquellen GmbH & Co KG, submitted for authorisation of 
a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent 
Authority of Germany, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was 
asked to deliver an opinion on the scientific substantiation of a health claim related to Rosbacher 
drive
®
 and increased attention. 
The scope of the application was proposed to fall under a health claim based on newly developed 
scientific evidence. The application included a request for the protection of proprietary data. 
The food that is the subject of the health claim is Rosbacher drive
®
, which contains natural mineral 
water plus grape juice (17.5 %), lemon juice (5 %), pomegranate juice (2 %), elderberry juice (0.5 %), 
isomaltulose (30 g/L), sucrose (15 g/L), fructose syrup (10 g/L), caffeine (100 mg/L), ascorbic acid 
(200 mg/L) and natural flavourings. The Panel considers that the food, Rosbacher drive
®
, which is the 
subject of the health claim, is sufficiently characterised. 
The claimed effect proposed by the applicant is “maintenance and increase in concentration”. The 
target population proposed by the applicant is “people wishing to support their mental performance”. 
Concentration, i.e. attention, refers to the ability to attend to, select and use incoming sensory 
information. Attention is a well-defined construct which can be measured by validated psychometric 
tests. The Panel considers that increased attention is a beneficial physiological effect. 
The applicant identified a total of 31 published studies and one unpublished study as being pertinent to 
the health claim. 
The 31 published studies were not carried out with a food complying with the characterisation of the 
food which is the subject of the claim. The Panel considers that no conclusions can be drawn from 
these studies for the scientific substantiation of the claim. 
Only one study carried out with Rosbacher drive
®
 was provided. This study was an open-label, non-
randomised sequential study which did not report on any outcomes of attention. The Panel considers 
that no conclusions can be drawn from this study for the scientific substantiation of the claim. 
The Panel concludes that a cause and effect relationship has not been established between the 
consumption of Rosbacher drive
®
 and increased attention. 
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BACKGROUND 
Regulation (EC) No 1924/2006
4
 harmonises the provisions that relate to nutrition and health claims, 
and establishes rules governing the Community authorisation of health claims made on foods. As a 
rule, health claims are prohibited unless they comply with the general and specific requirements of this 
Regulation, are authorised in accordance with this Regulation, and are included in the lists of 
authorised claims provided for in Articles 13 and 14 thereof. In particular, Article 13(5) of this 
Regulation lays down provisions for the addition of claims (other than those referring to the reduction 
of disease risk and to children’s development and health) which are based on newly developed 
scientific evidence, or which include a request for the protection of proprietary data, to the Community 
list of permitted claims referred to in Article 13(3). 
According to Article 18 of this Regulation, an application for inclusion in the Community list of 
permitted claims referred to in Article 13(3) shall be submitted by the applicant to the national 
competent authority of a Member State, which will make the application and any supplementary 
information supplied by the applicant available to the European Food Safety Authority (EFSA). 
STEPS TAKEN BY EFSA 
 The application was received on 15/05/2013. 
 The scope of the application was proposed to fall under a health claim based on newly 
developed scientific evidence. The application included a request for the protection of 
proprietary data. 
 On 05/07/2013, during the validation process of the application, EFSA sent a request to the 
applicant to provide missing information. 
 On 24/09/2013, EFSA received the missing information as submitted by the applicant. 
 The scientific evaluation procedure started on 10/10/2013. 
 On 22/11/2013, the Working Group on Claims of the NDA Panel agreed on a list of questions 
for the applicant to provide additional information to accompany the application. The clock 
was stopped on 03/12/2013 and restarted on 18/12/2013, in compliance with Article 18(3) of 
Regulation (EC) No 1924/2006. EFSA received the requested information on 24/01/2014, 
beyond the legal deadline (the information was made available to EFSA in electronic format 
on 22/01/2014). 
 During its meeting on 05/02/2014, the NDA Panel, having evaluated the data submitted, 
adopted an opinion on the scientific substantiation of a health claim related to Rosbacher 
drive
®
 and increased attention. 
TERMS OF REFERENCE 
EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with 
Article 16(3) of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an 
opinion on the scientific substantiation of a health claim related to: Rosbacher drive
®
 and increased 
attention. 
EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation for the marketing 
of Rosbacher drive
®
, a positive assessment of its safety, nor a decision on whether Rosbacher drive
®
 
is, or is not, classified as a foodstuff. It should be noted that such an assessment is not foreseen in the 
framework of Regulation (EC) No 1924/2006. 
                                                     
4 Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25. 
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It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of 
use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation 
procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006. 
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INFORMATION PROVIDED BY THE APPLICANT 
Applicant’s name and address: Hassia Mineralquellen GmbH & Co KG, Gießener Straße 30, 
D-61118 Bad Vilbel, Germany. 
The application includes a request for the protection of proprietary data for one unpublished study 
(Wagner et al., 2007), in accordance with Article 21 of Regulation (EC) No 1924/2006. 
Food/constituent as stated by the applicant 
According to the applicant, the food that is the subject of the health claim is an energy drink marketed 
as Rosbacher drive
®
 which contains as a basis natural mineral water plus grape juice (17.5 %), lemon 
juice (5 %), pomegranate juice (2 %), elderberry juice (0.5 %), isomaltulose (Palatinose
™
, 30 g/L), 
sucrose (15 g/L), fructose syrup (10 g/L), caffeine (100 mg/L), ascorbic acid (200 mg/L) as 
antioxidant agent and natural flavourings. The carbohydrate content in Rosbacher drive
®
, comprising 
sugars from fruit juices and added sugars, was indicated by the applicant as 30 g/L isomaltulose, 
25 g/L glucose and 35 g/L fructose. 
Health relationship as claimed by the applicant 
According to the applicant, the caffeine, glucose, fructose, sucrose and isomaltulose contained in 
Rosbacher drive
®
 support the intellectual ability/readiness to perform in situations of mental challenge 
[original in German: “fördert die geistige Leistungsbereitschaft bei mentalen Anforderungen”]. 
Wording of the health claim as proposed by the applicant 
The applicant proposed the following wording for the health claim: “helps/supports/maintains 
concentration” [original in German: “unterstützt die Konzentration”]. 
The following alternative wordings were proposed: “helps/supports/maintains the human ability to 
concentrate”, “stabilises concentration” [originals in German: “unterstützt die menschliche 
Konzentrationsfähigkeit”, “stabilisiert die Konzentration”]. 
Specific conditions of use as proposed by the applicant 
The applicant proposed the consumption of 500 mL of Rosbacher drive
®
 in order to obtain the claimed 
effect. 
The target population is people wishing to support their mental performance in certain situations, e.g. 
during studies, professional activities, while driving car or doing household chores [original in 
German: “wird für Personen/für Lebenssituationen empfohlen, in denen mentale Leistungsfähigkeit 
von Bedeutung ist, wie im Studium, im Beruf, beim Autofahren, im Haushaltsmanagement”]. 
ASSESSMENT 
1. Characterisation of the food/constituent 
The food that is the subject of the health claim is Rosbacher drive
®
, which is marketed as an “energy 
drink”. 
Rosbacher drive
®
 contains natural mineral water plus grape juice (17.5 %), lemon juice (5 %), 
pomegranate juice (2 %), elderberry juice (0.5 %), isomaltulose (Palatinose
™
, 30 g/L), sucrose 
(15 g/L), fructose syrup (10 g/L), caffeine (100 mg/L), ascorbic acid (as antioxidant agent, 200 mg/L) 
and natural flavourings. Rosbacher drive
®
 contains 25 g/L glucose and 35 g/L fructose comprising 
sugars from fruit juices and added sugars. 
Detailed product sheets for the various fruit juices in Rosbacher drive
®
 were provided. 
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The applicant stated that appropriate stability tests were carried out on the product and these tests 
showed compliance with the stability requirements of the product until the “best before” date. 
The Panel considers that the food, Rosbacher drive
®
, which is the subject of the health claim, is 
sufficiently characterised. 
2. Relevance of the claimed effect to human health 
The applicant indicated that the proposed claimed effect is “maintenance and increase in 
concentration”. The target population proposed by the applicant is “people wishing to support their 
mental performance”. 
Concentration, i.e. attention, refers to the ability to attend to, select and use incoming sensory 
information (i.e. to concentrate while processing information). There are two broad categories of 
attention. Selective attention is the ability to concentrate on one task or source of information to the 
exclusion of others. Sustained attention (vigilance) is the ability to concentrate over a period of time. 
Attention is a well-defined construct which can be measured by validated psychometric tests. 
The Panel considers that increased attention is a beneficial physiological effect. 
3. Scientific substantiation of the claimed effect 
The applicant performed a literature search in PubMed and Google using the search terms “glucose”, 
“carbohydrate”, “Palatinose”, “isomaltulose”, “caffeine”, “liquid”, “dehydration” and “fluidity” in 
combination with “cognition”, “intelligence”, “memory”, “reaction time”, “concentration”, “alertness” 
and “vigilance”. In addition, the applicant searched for pertinent studies in literature lists of CIAA 
(Confederation of food and drink industries of Europe), ERNA (European Responsible Nutrition 
Alliance), EHPM (European Federation of Associations of Health Product Manufacturers) and EBF 
(European Botanical Forum). Studies were included if they were carried out in humans and assessed 
the effects of hydration, caffeine, carbohydrates/glucose, or a combination of these, on the ability to 
concentrate. 
The Panel notes that a health claim on caffeine and increased attention has already been assessed with 
a favourable outcome (EFSA NDA Panel, 2011), and that the conditions of use for that claim were set 
at 75 mg caffeine per serving. The Panel also notes that with respect to the health claim under 
evaluation the consumption of 500 mL of Rosbacher drive
®
 (as proposed by the applicant as 
conditions of use for the claim) would lead to an intake of 50 mg caffeine. 
The applicant identified a total of 31 published studies and one unpublished study as being pertinent to 
the health claim. 
The 31 published studies were carried out with caffeine (17 studies), carbohydrates or isomaltulose 
(nine studies), and various combinations of caffeine plus carbohydrates (four studies). One study 
assessed the effect of dehydration on mental function. The Panel notes that these studies were not 
carried out with a food which complies with the specifications indicated in section 1 and considers that 
no conclusions can be drawn from these studies for the scientific substantiation of the claim. 
Only one study (Wagner et al., 2007, unpublished, claimed as proprietary by the applicant) was carried 
out with Rosbacher drive
®
. This study was an open-label, non-randomised sequential study in 10 male 
students. The primary outcome was alertness as measured by a self-rated questionnaire 
(“Alertometer”). The Panel notes that the primary outcome of the study was a subjective measure of 
alertness, which cannot be used as a measure of attention (EFSA NDA Panel, 2012). A number of 
other outcomes were provided which did not assess attention. The Panel considers that no conclusions 
can be drawn from this study for the scientific substantiation of the claim. 
The Panel concludes that a cause and effect relationship has not been established between the 
consumption of Rosbacher drive
®
 and increased attention. 
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CONCLUSIONS 
On the basis of the data presented, the Panel concludes that: 
 The food, Rosbacher drive®, which is the subject of the health claim, is sufficiently 
characterised. 
 The claimed effect proposed by the applicant is “maintenance and increase in concentration”. 
The target population proposed by the applicant is “people wishing to support their mental 
performance”. Increased attention is a beneficial physiological effect. 
 A cause and effect relationship has not been established between the consumption of 
Rosbacher drive
®
 and increased attention. 
DOCUMENTATION PROVIDED TO EFSA 
Health claim application on Rosbacher drive
®
 and increased attention pursuant to Article 13(5) of 
Regulation (EC) No 1924/2006 (Claim serial No: 0382_DE). May 2013. Submitted by Hassia 
Mineralquellen GmbH & Co KG. 
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